These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 38270844)

  • 1. Special features on insulin resistance, metabolic syndrome and vascular complications in hypopituitary patients.
    Garmes HM
    Rev Endocr Metab Disord; 2024 Jun; 25(3):489-504. PubMed ID: 38270844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone replacement normalizes impaired fibrinolysis: new insights into endothelial dysfunction in patients with hypopituitarism and growth hormone deficiency.
    Miljic D; Miljic P; Doknic M; Pekic S; Stojanovic M; Cvijovic G; Micic D; Popovic V
    Growth Horm IGF Res; 2013 Dec; 23(6):243-8. PubMed ID: 24041757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Syndrome in Hypopituitarism.
    Miljić D; Popovic V
    Front Horm Res; 2018; 49():1-19. PubMed ID: 29895033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
    Verhelst J; Kendall-Taylor P; Erfurth EM; Price DA; Geffner M; Koltowska-Häggström M; Jönsson PJ; Wilton P; Abs R
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance, metabolic syndrome and chronic low grade inflammation in Sheehan's syndrome on standard replacement therapy: a case control study.
    Bhat MA; Laway BA; Shah ZA; Wani AI; Mubarik I
    Pituitary; 2015 Jun; 18(3):312-8. PubMed ID: 24879499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and its components in adult hypopituitary patients.
    Abe SY; Dos Santos KS; Barbosa BFB; Biondo CMP; Takito D; Hayashi SK; Amarilla VGV; Ulbrich AZ; Boguszewski CL
    Pituitary; 2020 Aug; 23(4):409-416. PubMed ID: 32418172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DIFFERENTIAL REGULATION OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVITY IN PATIENTS WITH DIFFERING ETIOLOGIES OF HYPOPITUITARISM.
    Agha A; Behan LA; Forde H; Taylor NF; Smith D; Thompson CJ; Drake WM; Monson JP
    Endocr Pract; 2018 Oct; 24(10):875-881. PubMed ID: 29975580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic consequences of GH deficiency.
    Jørgensen JO; Vestergaard E; Gormsen L; Jessen N; Nørrelund H; Christiansen JS; Møller N
    J Endocrinol Invest; 2005; 28(5 Suppl):47-51. PubMed ID: 16114276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY.
    Xie X; Li Q; Zhang L; Ren W
    Endocr Pract; 2018 Jan; 24(1):33-39. PubMed ID: 29144802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic changes and vascular risk factors in hypopituitarism.
    Johnston DG; Beshyah SA; Markussis V; Shahi M; Sharp PS; Foale RA; Skinner EM
    Horm Res; 1992; 38 Suppl 1():68-72. PubMed ID: 1295816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone replacement in adults with growth hormone deficiency: assessment of current knowledge.
    Carroll PV; Christ ER; Sönksen PH
    Trends Endocrinol Metab; 2000 Aug; 11(6):231-8. PubMed ID: 10878754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary growth hormone (GH) secretion is partially rescued in HIV-infected patients with GH deficiency (GHD) compared to hypopituitary patients.
    Diazzi C; Brigante G; Ferrannini G; Ansaloni A; Zirilli L; De Santis MC; Zona S; Guaraldi G; Rochira V
    Endocrine; 2017 Mar; 55(3):885-898. PubMed ID: 27730472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The consequences of growth hormone deficiency in adulthood, and the effects of growth hormone replacement.
    Christ ER; Carroll PV; Russell-Jones DL; Sönksen PH
    Schweiz Med Wochenschr; 1997 Aug; 127(35):1440-9. PubMed ID: 9297747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative growth hormone (GH) peak values during a GH releasing peptide-2 test reflect the severity of hypopituitarism and the postoperative recovery of GH secretion in patients with non-functioning pituitary adenomas.
    Soga A; Fukuda I; Kobayashi S; Tahara S; Morita A; Sugihara H
    Endocr J; 2020 Feb; 67(2):167-175. PubMed ID: 31776295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of hormone replacement therapy in young GH-treated hypopituitary women increases liver enzymes.
    Høst C; Christiansen JJ; Christiansen JS; Jorgensen JO; Gravholt CH
    Growth Horm IGF Res; 2010 Feb; 20(1):26-30. PubMed ID: 19660970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term GH replacement therapy on cardiovascular outcomes in isolated GH deficiency compared with multiple pituitary hormone deficiencies: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Bunderen CC; van den Dries CJ; Heymans MW; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    Eur J Endocrinol; 2014 Aug; 171(2):151-60. PubMed ID: 24801587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
    Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.